Cytogenetic support for early malignant change in a diffuse neurofibroma not associated with neurofibromatosis

Cancer Genetics and Cytogenetics

Volumn 97, Issue 1, 1997, Pages 70-72

  Molenaar, Willemina M ^a,b   Dijkhuizen, Trijnie ^a   Van Echten, Jannie ^a   Hoekstra, Harald J ^a   Van Den Berg, Eva ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Pathology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CYTOGENETICS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; KARYOTYPE; LEG AMPUTATION; MALIGNANT TRANSFORMATION; MAST CELL; MITOSIS RATE; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TUMOR GROWTH;

CHROMOSOME ABERRATIONS; FEMALE; HUMANS; KARYOTYPING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROFIBROMA; RING CHROMOSOMES; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

POMACANTHUS MACULOSUS;

EID: 0031213813     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00331-7     Document Type: Article

References (15)

1. 1. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
2. 2. Von Deimling A, Krone W, Menon AG (1995): Neurofibromatosis type 1: Pathology, clinical features and molecular genetics. Brain Pathol 5:153-162.
3. 3. Becher R, Wake N, Gibas Z, Ochi H, Sandberg AA (1984): Chromosome changes in soft tissue sarcomas. J Natl Cancer Instit 72:823-831.
4. 4. Riccardi VM, Elder DW (1996): Multiple cytogenetic aberrations in neurofibrosarcomas complicating neurofibromatosis. Cancer Genet Cytogonet 23:199-209.
5. 5. Docker H-JH, Cannizzaro LA, Mondez MJ, Leong SPL, Bixenman H, Berger C, Sandberg AA (1990): Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study. Hum Genet 85:337-342.
6. 6. Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, Pinkus GS, Morton CC, Corson JM (1991): Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 324:436-443.
7. 7. Glover TW, Stein CK, Legius R, Andersen LB, Brereton A, Johnson S (1991): Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosom Cancer 3:62-70.
8. 8. Bello MJ, De Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestan A, Rey JA (1993): Clonal chromosome aberrations in neurinomas. Genes Chromosom Cancer 6:206-211.
9. 9. Rey JA, Bello MJ, De Campos JM, Vaquoro J, Kusak ME, Sarasa JL, Pestana A (1993): Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches. Cancer Genet Cytogenet 66:1-10.
10. 10. Rey JA, Bello MJ, Kusak ME, De Campos JM, Pestana A (1993): Involvement of 2q12 in a neurofibrosarcoma in neurofibromatosis type 1. Cancer Genet Cytogenet: 66:28-32.
11. 11. Travis JA, Sandber AA, Neff JR, Bridge JA (1994): Cytogenetic findings in malignant triton tumor. Genes Chromosom Cancer 9:1-7.
12. 12. Mertens F, Rydholm A, Bauer HFC, Limon J, Nedoszytko B, Szadowska A, Willén H, Heim S, Mitelman F, Mandahl N (1995): Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer 61:793-798.
13. 13. Mertens F, Heim S, Kullendorff C-M, Donner M, Hägerstrand I, Mitelman F, Mandahl N (1995): Clonal karyotypic evolution in a pediatric neurofibrosarcoma. Cancer Genet Cytogenet 81:135-138.
14. 14. Sandberg AA, Bridge JA (1994): The Cytogenetics of Bone and Soft Tissue Tumors. R.G. Landes Co, Austin.
15. 15. Heim S, Mitelman F (1995): Cancer Cytogenetics. Wiley-Liss, New York.